Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112034
Status:
COMPLETED
Last Update Posted:
2008-05-09
First Post:
2005-05-27
Brief Title:
AVONEX Combination Trial - ACT
Sponsor:
Biogen
Organization:
Biogen
Study Overview
Official Title:
A Multi-Center Randomized Blinded Parallel-Group Study of AVONEX Compared With AVONEX in Combination With Oral Methotrexate Intravenous Methylprednisolone or Both in Subjects With Relapsing Remitting MS Who Have Breakthrough Disease on AVONEX Monotherapy
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the efficacy and safety of combination therapy with AVONEX plus low dose oral methotrexate MTX every other month courses of intravenous methylprednisolone IVMP or both in patients with continued disease activity on AVONEX monotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None